Kay NE - Search Results

1

Genetic susceptibility variants for chronic lymphocytic leukemia.

Slager SL, Goldin LR, Strom SS, Lanasa MC, Spector LG, Rassenti L, Leis JF, Camp NJ, Kay NE, Vachon CM, Glenn M, Weinberg JB, Rabe KG, Cunningham JM, Achenbach SJ, Hanson CA, Marti GE, Call TG, Caporaso NE, Cerhan JR. Slager SL, et al. Among authors: kay ne. Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1098-102. doi: 10.1158/1055-9965.EPI-09-1217. Epub 2010 Mar 23. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20332261 Free PMC article.

2

Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis.

Kay NE, Han L, Bone N, Williams G. Kay NE, et al. Br J Haematol. 2001 Mar;112(3):760-7. doi: 10.1046/j.1365-2141.2001.02605.x. Br J Haematol. 2001. PMID: 11260081 Free article.

3

Angiogenesis in B-chronic lymphocytic leukemia.

Kay NE, Jelinek DF, Peterson L. Kay NE, et al. Leuk Res. 2001 Jun;25(6):485-6. doi: 10.1016/s0145-2126(01)00008-x. Leuk Res. 2001. PMID: 11337021 No abstract available.

4

Angiogenesis in B-chronic lymphocytic leukemia.

Kay NE, Jelinek DF, Peterson L. Kay NE, et al. Leuk Res. 2001 Aug;25(8):709-10. doi: 10.1016/s0145-2126(01)00002-9. Leuk Res. 2001. PMID: 11397477 No abstract available.

5

Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.

Jelinek DF, Tschumper RC, Geyer SM, Bone ND, Dewald GW, Hanson CA, Stenson MJ, Witzig TE, Tefferi A, Kay NE. Jelinek DF, et al. Among authors: kay ne. Br J Haematol. 2001 Dec;115(4):854-61. doi: 10.1046/j.1365-2141.2001.03149.x. Br J Haematol. 2001. PMID: 11843819 Free article.

6

B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.

Kay NE, Bone ND, Tschumper RC, Howell KH, Geyer SM, Dewald GW, Hanson CA, Jelinek DF. Kay NE, et al. Leukemia. 2002 May;16(5):911-9. doi: 10.1038/sj.leu.2402467. Leukemia. 2002. PMID: 11986954

7

Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study.

Cerhan JR, Janney CA, Vachon CM, Habermann TM, Kay NE, Potter JD, Sellers TA, Folsom AR. Cerhan JR, et al. Among authors: kay ne. Am J Epidemiol. 2002 Sep 15;156(6):527-35. doi: 10.1093/aje/kwf082. Am J Epidemiol. 2002. PMID: 12226000

8

Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival.

Novak AJ, Bram RJ, Kay NE, Jelinek DF. Novak AJ, et al. Among authors: kay ne. Blood. 2002 Oct 15;100(8):2973-9. doi: 10.1182/blood-2002-02-0558. Blood. 2002. PMID: 12351410 Free article.

9

Chronic lymphocytic leukemia.

Kay NE, Hamblin TJ, Jelinek DF, Dewald GW, Byrd JC, Farag S, Lucas M, Lin T. Kay NE, et al. Hematology Am Soc Hematol Educ Program. 2002:193-213. doi: 10.1182/asheducation-2002.1.193. Hematology Am Soc Hematol Educ Program. 2002. PMID: 12446424 Review.

10

Identification of a global gene expression signature of B-chronic lymphocytic leukemia.

Jelinek DF, Tschumper RC, Stolovitzky GA, Iturria SJ, Tu Y, Lepre J, Shah N, Kay NE. Jelinek DF, et al. Among authors: kay ne. Mol Cancer Res. 2003 Mar;1(5):346-61. Mol Cancer Res. 2003. PMID: 12651908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page